Purpose: Less than 5% of patients with cancer participate in trials. Few studies have
specifically addressed the role of cost to the patient as an influence on trial participation. Our …

Although clinical trial research is required for the development of improved treatment
strategies, very few cancer patients participate in these studies. The purpose of this study …

Background Clinical trials are necessary for the advancement of cancer treatment and care,
however low rates of participation in such trials limit the generalisability of findings. The …

Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But although barriers
to trial participation have been the subject of frequent study, the rate of trial participation has …

74 Background: The successful conduct of cancer clinical trials hinges on the willingness of
patients to participate. The rate of adult clinical trial participation has been regarded as …

6015 Background: Multiple factors determine whether or not cancer pts enter a clinical trial.
To find some of these causes, a seven physician MedOnc/Hem practice with access to …

Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …

OBJECTIVE: To investigate the barriers, modifiers, and benefits involved in participating in
randomized controlled trials of cancer therapies as perceived by health care providers and …

Everyone agrees that optimal medical care should be based upon a database of evidence
derived from patients participating in comparative randomized clinical trials. Unfortunately …